Recent filings by Lupin Limited

Published Title Summary
2026-04-01 19:21:12 Acquisition-XBRL Lupin Limited has informed the Exchange regarding Acquisition...
Lupin Limited has informed the Exchange regarding Acquisition
2026-04-01 18:42:52 Acquisition Lupin Limited has informed the Exchange about signing of definitive...
Lupin Limited has informed the Exchange about signing of definitive agreement for Acquisition of minority shareholding in Multicare Pharmaceuticals Philippines, Inc., by Nanomi B.V., the Netherlands, a wholly owned subsidiary of the Company.
2026-03-30 10:23:01 Acquisition-XBRL Lupin Limited has informed the Exchange regarding Acquisition...
Lupin Limited has informed the Exchange regarding Acquisition
2025-09-29 14:31:06 Acquisition-XBRL Lupin Limited has informed the Exchange regarding Acquisition...
Lupin Limited has informed the Exchange regarding Acquisition
2025-09-29 06:44:53 Acquisition Lupin Limited has informed the Exchange that Nanomi B.V., the...
Lupin Limited has informed the Exchange that Nanomi B.V., the Netherlands, a wholly owned subsidiary of the Company in Netherlands, has entered into a definitive agreement to acquire the entire share capital of VISUfarma B.V., headquartered in Amsterdam, the Netherlands.
2025-05-23 18:36:46 Acquisition-XBRL LUPIN LIMITED has informed the Exchange regarding Acquisition...
LUPIN LIMITED has informed the Exchange regarding Acquisition
2025-05-23 17:50:50 Acquisition Lupin Limited has informed the Exchange about Disclosure pursuant to...
Lupin Limited has informed the Exchange about Disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
2025-04-02 19:10:22 Acquisition-XBRL Lupin Limited has informed the Exchange regarding Acquisition...
Lupin Limited has informed the Exchange regarding Acquisition
2025-04-02 19:06:57 Acquisition Lupin Limited has informed the Exchange about Lupin Healthcare (UK)...
Lupin Limited has informed the Exchange about Lupin Healthcare (UK) Limited, a wholly owned subsidiary of the Company having acquired the entire share capital of Renascience Pharma Limited, United Kingdom.
2025-01-27 17:53:31 Board Meeting Intimation Lupin Limited has informed the Exchange about Board Meeting to...
Lupin Limited has informed the Exchange about Board Meeting to be held on 11-Feb-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Other business.
2025-01-09 21:40:14 Acquisition Lupin Limited has informed the Exchange about completion of the...
Lupin Limited has informed the Exchange about completion of the acquisition of 42.61% of the equity share capital of Sunsure Solarpark Seventeen Private Limited, in the capacity as a Captive User.
2024-09-11 16:32:05 Acquisition-XBRL Lupin Limited has informed the Exchange regarding Acquisition...
Lupin Limited has informed the Exchange regarding Acquisition
2024-09-11 16:23:15 Acquisition Lupin Limited has informed the Exchange about signing of Share...
Lupin Limited has informed the Exchange about signing of Share Subscription & Shareholder's Agreement with Sunsure Solarpark Seventeen Private Limited and Sunsure Energy Private Limited to make equity investment in Sunsure Solarpark Seventeen Private Limited in the capacity as a Captive User.
2024-07-23 12:09:41 Board Meeting Intimation Lupin Limited has informed the Exchange about Board Meeting to...
Lupin Limited has informed the Exchange about Board Meeting to be held on 06-Aug-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and Other business.